114 related articles for article (PubMed ID: 37338022)
1. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
2. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
[TBL] [Abstract][Full Text] [Related]
3. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
4. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis.
Song L; Jia J; Peng X; Xiao W; Li Y
Sci Rep; 2017 Jun; 7(1):3032. PubMed ID: 28596563
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the clinical performance of
Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W
Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561
[TBL] [Abstract][Full Text] [Related]
6. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.
Ahlquist DA; Zou H; Domanico M; Mahoney DW; Yab TC; Taylor WR; Butz ML; Thibodeau SN; Rabeneck L; Paszat LF; Kinzler KW; Vogelstein B; Bjerregaard NC; Laurberg S; Sørensen HT; Berger BM; Lidgard GP
Gastroenterology; 2012 Feb; 142(2):248-56; quiz e25-6. PubMed ID: 22062357
[TBL] [Abstract][Full Text] [Related]
7.
Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of blood diagnostic markers in colorectal cancer.
Nikolaou S; Qiu S; Fiorentino F; Rasheed S; Tekkis P; Kontovounisios C
Tech Coloproctol; 2018 Jul; 22(7):481-498. PubMed ID: 30022330
[TBL] [Abstract][Full Text] [Related]
9. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis.
Rezkitha YAA; Panenggak NSR; Lusida MI; Rianda RV; Mahmudah I; Pradana AD; Uchida T; Miftahussurur M
J Med Life; 2024 Jan; 17(1):4-14. PubMed ID: 38737656
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA.
Ruiz-Bañobre J; Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; Alvarez-Castro A; Carreras-Presas M; Brozos-Vazquez E; Vidal-Insua Y; Vazquez-Rivera F; Candamio-Folgar S; Mosquera-Presedo M; Lago-Lestón RM; Muinelo-Romay L; Vázquez-Bueno JÁ; Sanz-Pamplona R; Moreno V; Goel A; Castillo L; Martin AC; Arroyo R; Esteller M; Crujeiras AB; López-López R; Díaz-Lagares A
Clin Epigenetics; 2022 Jul; 14(1):86. PubMed ID: 35810318
[TBL] [Abstract][Full Text] [Related]
11. Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy.
Hariharan R; Jenkins M
BMJ Open Gastroenterol; 2020; 7(1):e000355. PubMed ID: 32128229
[TBL] [Abstract][Full Text] [Related]
12. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
Chung DC; Gray DM; Singh H; Issaka RB; Raymond VM; Eagle C; Hu S; Chudova DI; Talasaz A; Greenson JK; Sinicrope FA; Gupta S; Grady WM
N Engl J Med; 2024 Mar; 390(11):973-983. PubMed ID: 38477985
[TBL] [Abstract][Full Text] [Related]
13. Use of Enzymatically Converted Cell-Free DNA (cfDNA) Data for Copy Number Variation-Linked Fragmentation Analysis Allows for Early Colorectal Cancer Detection.
Černoša I; Trincado-Alonso F; Canal-Noguer P; Kruusmaa K; Perera-Lluna A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542469
[TBL] [Abstract][Full Text] [Related]
14. Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer: which is ready for prime time?
Danese E; Montagnana M; Lippi G
Ann Transl Med; 2019 Nov; 7(21):610. PubMed ID: 32047771
[TBL] [Abstract][Full Text] [Related]
15. Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.
Ionescu EM; Nicolaie T; Ionescu MA; Becheanu G; Andrei F; Diculescu M; Ciocirlan M
J Med Life; 2015; 8(3):398-403. PubMed ID: 26351547
[TBL] [Abstract][Full Text] [Related]
16. Multimodal epigenetic sequencing analysis (MESA) of cell-free DNA for non-invasive colorectal cancer detection.
Li Y; Xu J; Chen C; Lu Z; Wan D; Li D; Li JS; Sorg AJ; Roberts CC; Mahajan S; Gallant MA; Pinkoviezky I; Cui Y; Taggart DJ; Li W
Genome Med; 2024 Jan; 16(1):9. PubMed ID: 38225592
[TBL] [Abstract][Full Text] [Related]
17. Early screening of colorectal cancer using feature engineering with artificial intelligence-enhanced analysis of nanoscale chromatin modifications.
Chang A; Prabhala S; Daneshkhah A; Lin J; Subramanian H; Roy HK; Backman V
Sci Rep; 2024 Apr; 14(1):7808. PubMed ID: 38565871
[TBL] [Abstract][Full Text] [Related]
18. Case-control study of candidate gene methylation and adenomatous polyp formation.
Alexander M; Burch JB; Steck SE; Chen CF; Hurley TG; Cavicchia P; Shivappa N; Guess J; Zhang H; Youngstedt SD; Creek KE; Lloyd S; Jones K; Hébert JR
Int J Colorectal Dis; 2017 Feb; 32(2):183-192. PubMed ID: 27771773
[TBL] [Abstract][Full Text] [Related]
19. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population.
Luo WF; Jiao YT; Lin XL; Zhao Y; Wang SB; Shen J; Deng J; Ye YF; Han ZP; Xie FM; He JH; Wan Y
World J Gastrointest Oncol; 2024 Apr; 16(4):1361-1373. PubMed ID: 38660655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
